185 related articles for article (PubMed ID: 30583040)
1. Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
Zakeri K; Narayanan D; Vikram B; Evans G; Coleman CN; Prasanna PGS
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):188-196. PubMed ID: 30583040
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program.
Zakeri K; Narayanan D; Prasanna PGS; Vikram B; Buchsbaum JC
Radiat Res; 2020 May; 193(5):425-434. PubMed ID: 32216707
[TBL] [Abstract][Full Text] [Related]
3. Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.
Prasanna PG; Narayanan D; Hallett K; Bernhard EJ; Ahmed MM; Evans G; Vikram B; Weingarten M; Coleman CN
Radiat Res; 2015 Sep; 184(3):235-48. PubMed ID: 26284423
[TBL] [Abstract][Full Text] [Related]
4. Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research Pathway.
Zakeri K; Narayanan D; Evans G; Prasanna P; Buchsbaum JC; Vikram B; Capala J
J Nucl Med; 2019 Jan; 60(1):41-49. PubMed ID: 30030338
[TBL] [Abstract][Full Text] [Related]
5. Investor initiatives program: Public-private partnerships to expedite commercialization for NCI-funded small business entrepreneurs.
Connors B; Lou XJ; Subedee A; Zhang K; Weingarten M; Narayanan D
Clin Transl Sci; 2021 Nov; 14(6):2124-2131. PubMed ID: 34387931
[TBL] [Abstract][Full Text] [Related]
6. Can the SBIR and STTR programs advance research goals?
Ceulemans S; Kolls JK
Nat Immunol; 2013 Mar; 14(3):192-5. PubMed ID: 23416667
[TBL] [Abstract][Full Text] [Related]
7. Geographically-related outcomes of U.S. funding for small business research and development: Results of the research grant programs of a component of the National Institutes of Health.
Onken J; Aragon R; Calcagno AM
Eval Program Plann; 2019 Dec; 77():101696. PubMed ID: 31404866
[TBL] [Abstract][Full Text] [Related]
8. Using database linkages to measure innovation, commercialization, and survival of small businesses.
Onken J; Miklos AC; Dorsey TF; Aragon R; Calcagno AM
Eval Program Plann; 2019 Dec; 77():101710. PubMed ID: 31518846
[TBL] [Abstract][Full Text] [Related]
9. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
10. National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points.
Ghazarian AL; Haim T; Sauma S; Katiyar P
Alzheimers Dement; 2022 Feb; 18(2):348-359. PubMed ID: 34374496
[TBL] [Abstract][Full Text] [Related]
11. CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneurs.
Pond MA; Narayanan D; Zhang K; Fau D; Summers J; Carranza D; Weingarten M
Clin Transl Sci; 2023 Mar; 16(3):412-421. PubMed ID: 36601678
[TBL] [Abstract][Full Text] [Related]
12. Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?
Prasanna PGS; Narayanan D; Zhang K; Rahbar A; Coleman CN; Vikram B
Radiat Res; 2020 Mar; 193(3):199-208. PubMed ID: 31910120
[TBL] [Abstract][Full Text] [Related]
13. Creative partnerships for funding nursing research.
McCann JJ; Hills EB; Zauszniewski JA; Smith CE; Farran CJ; Wilkie DJ
West J Nurs Res; 2011 Feb; 33(1):79-105. PubMed ID: 20719996
[TBL] [Abstract][Full Text] [Related]
14. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
15. Fostering Diversity and Inclusion in the National Heart, Lung, and Blood Institute's Small Business Program.
Padmore EW; McMahon MJ
Ethn Dis; 2019; 29(Suppl 1):71-76. PubMed ID: 30906152
[TBL] [Abstract][Full Text] [Related]
16. National Cancer Institute support for targeted alpha-emitter therapy.
Hong JA; Brechbiel M; Buchsbaum J; Canaria CA; Coleman CN; Escorcia FE; Espey M; Kunos C; Lin F; Narayanan D; Capala J
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):64-72. PubMed ID: 34378064
[TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.
Vener KJ
Fed Proc; 1985 Aug; 44(11):2679-84. PubMed ID: 4018273
[TBL] [Abstract][Full Text] [Related]
18. Aspects of research and development contract terms in the bio/pharmaceutical sector.
Banerjee T
Adv Health Econ Health Serv Res; 2012; 23():1-33. PubMed ID: 23156659
[TBL] [Abstract][Full Text] [Related]
19. Advancing pediatric medical device development via non-dilutive NIH SBIR/STTR grant funding.
Sun RC; Kamat I; Byju AG; Wettergreen M; Heffernan MJ; Willson R; Haridas B; Koh CJ
J Pediatr Surg; 2021 Nov; 56(11):2118-2123. PubMed ID: 33558071
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
